Nasdaq Stockholm AB: New equity right for trading, Elicera Therapeutics TO1 (387/21)

At the request of Elicera Therapeutics AB, new equity right will be traded on
First North Growth Market as from July 7, 2021. 

Security name: Elicera Therapeutics TO1
----------------------------------------
Short name:   ELIC TO1        
----------------------------------------
ISIN code:   SE0015988233      
----------------------------------------
Orderbook ID:  226311         
----------------------------------------

Terms in    Two (2) warrants ELIC TO1 entitles for subscription of one (1)  
 short:     ELIC share. Subscription price 11.60 SEK.            
--------------------------------------------------------------------------------
                                        
--------------------------------------------------------------------------------
Subscription  From November 1, 2022 until and including November 30, 2022.   
 period:                                    
--------------------------------------------------------------------------------
Last trading  November 25, 2022                        
 day:                                      
--------------------------------------------------------------------------------

This information is distributed at the request of the Certified Adviser, G&W
Fondkommission. For further information, please call G&W Fondkommissionat
08-505 000 50.